Skip to content

Investigating the effect of Salvia officinalis capsules on the severity of postpartum pain in multiparous women

Investigating the effect of Salvia officinalis capsules on the severity of postpartum pain in multiparous women

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20100130003226N24
Enrollment
100
Registered
2024-12-12
Start date
2024-12-21
Completion date
Unknown
Last updated
2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postpartum pain. Pelvic and perineal pain

Interventions

Intervention 1: Intervention group: 2 hours after delivery, every 8 hours to 24 hours, one capsule containing 500 mg of Salvia officinalis and 250 mg of Mefenamic Acid is given and half an hour, one h

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Age between 18 and 35 years At least be able to read and write vaginal delivery Gestational age between 37 and 42 weeks the labor pain is moderate to severe Delivery should not be operative Absence of grade 3 and 4 perineal tears No history of chronic diseases like diabetes and hypertension No history of caesarean section and abdominal incisions Not using epidural and spinal anesthesia during labor and delivery No drug addiction A healthy and single tone baby Absence of birth complications like hemorrhage, fever, and hypertension in the mother Second, third and fourth deliveries The baby weighs between 2,500 and 4,000 gr The placenta and fetal membrane have been removed spontaneously

Exclusion criteria

Exclusion criteria: Unwillingness to participate in the study The occurrence of drug allergy Using pain killers other than the studied ones

Design outcomes

Primary

MeasureTime frame
Postpartum pain. Timepoint: Before the intervention - half an hour, one hour and two hours after the intervention. Method of measurement: Using a McGill pain ruler.

Secondary

MeasureTime frame
Side effects of the drug. Timepoint: After the intervention. Method of measurement: Drug side effects questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Mahrokh Dolatian

Shahid Beheshti University of Medical Sciences

mhdolatian@gmail.com+98 21 4913 1678

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026